New York City-based Memorial Sloan Kettering Cancer Center and National Cancer Institute researchers created an artificial intelligence tool that uses routine clinical data to predict the best immunotherapy drug and how a patient’s cancer will respond to it.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
